Hepatotoxicity associated with ribociclib among breast cancer patients

Acta Oncol. 2021 Feb;60(2):195-198. doi: 10.1080/0284186X.2020.1853228. Epub 2020 Dec 4.

Authors

Stefania Finnsdottir¹, Asgerdur Sverrisdottir², Einar S Björnsson^{1

3}

Affiliations

¹ Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
² Department of Oncology, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.
³ Department of Internal Medicine, Division of Gastroenterology and Hepatology, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.

PMID: 33272079
DOI: 10.1080/0284186X.2020.1853228

No abstract available

Publication types

Letter

MeSH terms

Aminopyridines / adverse effects
Breast Neoplasms* / drug therapy
Chemical and Drug Induced Liver Injury* / etiology
Female
Humans
Purines / adverse effects

Substances

Aminopyridines
Purines
ribociclib